Heartburn drug Ranitidine suspended
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Monday
August 08, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
MONDAY, AUGUST 08, 2022
Heartburn drug Ranitidine suspended

Health

TBS Report
14 November, 2019, 03:40 pm
Last modified: 14 November, 2019, 07:49 pm

Related News

  • Taliban bans drug cultivation, including lucrative opium
  • Brazil's Supreme Court suspends Telegram, a key Bolsonaro platform
  • UK travellers banned from entering Germany
  • Bengal BJP leader Rahul Sinha banned from campaigning for 48 hours
  • Indo-Bangla Pharmaceuticals’ production, marketing banned

Heartburn drug Ranitidine suspended

Raw materials of the two Indian supplier companies–Saraka Laboratories Limited and SMS Life Science have been examined.

TBS Report
14 November, 2019, 03:40 pm
Last modified: 14 November, 2019, 07:49 pm
Heartburn drug Ranitidine suspended

The government today imposed a suspension on the import, production and sale of heartburn drug Ranitidine made with ingredients of two Indian firms in the country.

A public announcement was made by the Director-General of Drug Administration Major General Mohammad Mahbubur Rahman in this regard.

Raw materials of the two Indian supplier companies–Saraka Laboratories Limited and SMS Life Science have been examined in the World Health Organisation accredited laboratory under the management of the department.

The test revealed higher than normal levels of MDMA impurity which is harmful to human health.

"After examining raw material used for manufacturing Ranitidine, we found the presence of harmful elements. That's why we suspended its production, sale and export until further instructions. Drug companies will recall Ranitidine from the market, under the supervision of our drug supers," Mahbubur Rahman said.

On September 29, the drug administration imposed a temporary suspension on the import of raw materials of Ranitidine.

The decision came after a research paper published by the US Food and Drug Administration and European Medicines Agency on September 13 found the presence of N-Nitrosodimethylamine – which contains cancer-causing elements – in Ranitidine. 

Bangladesh / Top News

Ranitidine / Banned

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • TBS file photo
    Now 99% Bangladesh products come under China’s duty-free offer
  • Photo: TBS
    Production loss feared as zone-wise industrial weekly closure mulled 
  • Representational image. File Photo: Minhaj Uddin/TBS
    LC settlement fell by $1.17b in July

MOST VIEWED

  • Photo: Collected
    Bangladesh lags in addressing post-Covid challenges: Experts
  • Photo: Collected
    No death from Covid-19 in 24 hours
  • Representational image. Picture: Collected
    Children aged 5-11 to get Covid jabs from 11 August
  • Photo: TBS
    BCSIR develops low-priced Covid test kits
  • Photo: Collected
    Covid-19: 2 deaths, 220 cases reported in 24hrs
  • Photo: Collected
    Indian startup Healthians enter Bangladesh, UAE markets 

Related News

  • Taliban bans drug cultivation, including lucrative opium
  • Brazil's Supreme Court suspends Telegram, a key Bolsonaro platform
  • UK travellers banned from entering Germany
  • Bengal BJP leader Rahul Sinha banned from campaigning for 48 hours
  • Indo-Bangla Pharmaceuticals’ production, marketing banned

Features

Safa Shareef’s bridal make-up: Contemporary with a ‘deshi’ touch

Safa Shareef’s bridal make-up: Contemporary with a ‘deshi’ touch

13h | Mode
Infograph: TBS

Why a drastic fuel price hike is dangerous

1d | Panorama
A fuel price hike to fuel agony

A fuel price hike to fuel agony

1d | Panorama
Kamal Uddin Mazumder. Sketch: TBS

Rising foreign debt and balance of payments deficit: Does Bangladesh need to worry?

1d | Thoughts

More Videos from TBS

How Google Maps operates in Bangladesh

How Google Maps operates in Bangladesh

3h | Videos
Is BPC really in loss?

Is BPC really in loss?

4h | Videos
Reasons behind Putin-Erdogan's meeting in Sochi

Reasons behind Putin-Erdogan's meeting in Sochi

8h | Videos
Dr Jamaluddin Ahmed talks about recent fuel price hike

Dr Jamaluddin Ahmed talks about recent fuel price hike

8h | Videos

Most Read

1
Diesel price hiked by Tk34 per litre, Octane by Tk46
Energy

Diesel price hiked by Tk34 per litre, Octane by Tk46

2
July remittance hits two-year high
Economy

July remittance hits two-year high

3
5,400 Bangladeshis get work visas to Romania
Migration

5,400 Bangladeshis get work visas to Romania

4
Housing projects sprouting up by Dhaka-Mawa expressway
Real Estate

Housing projects sprouting up by Dhaka-Mawa expressway

5
How banks made millions from volatile dollar 
Banking

How banks made millions from volatile dollar 

6
Infographic: TBS
Banking

Dollar rate will be left to market after two months: Governor

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net